EDNRA and breast cancer: The binding of Endothelin-1 (ET-1) to ET-1 receptor can stimulate growth of breast cancer cells by autocrine and paracrine signaling, and increased expression of ET-1, Endothelin A receptor (ETAR), and Endothelin B receptor (ETBR) in breast cancer patients lowers disease-free survival time and overall survival [50].